Cargando…

A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells

Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jozefczuk, Justyna, Kashofer, Karl, Ummanni, Ramesh, Henjes, Frauke, Rehman, Samrina, Geenen, Suzanne, Wruck, Wasco, Regenbrecht, Christian, Daskalaki, Andriani, Wierling, Christoph, Turano, Paola, Bertini, Ivano, Korf, Ulrike, Zatloukal, Kurt, Westerhoff, Hans V., Lehrach, Hans, Adjaye, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432516/
https://www.ncbi.nlm.nih.gov/pubmed/22969728
http://dx.doi.org/10.3389/fphys.2012.00339
_version_ 1782242217955426304
author Jozefczuk, Justyna
Kashofer, Karl
Ummanni, Ramesh
Henjes, Frauke
Rehman, Samrina
Geenen, Suzanne
Wruck, Wasco
Regenbrecht, Christian
Daskalaki, Andriani
Wierling, Christoph
Turano, Paola
Bertini, Ivano
Korf, Ulrike
Zatloukal, Kurt
Westerhoff, Hans V.
Lehrach, Hans
Adjaye, James
author_facet Jozefczuk, Justyna
Kashofer, Karl
Ummanni, Ramesh
Henjes, Frauke
Rehman, Samrina
Geenen, Suzanne
Wruck, Wasco
Regenbrecht, Christian
Daskalaki, Andriani
Wierling, Christoph
Turano, Paola
Bertini, Ivano
Korf, Ulrike
Zatloukal, Kurt
Westerhoff, Hans V.
Lehrach, Hans
Adjaye, James
author_sort Jozefczuk, Justyna
collection PubMed
description Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to increase. Differences in susceptibility to steatohepatitis and its progression to cirrhosis have been attributed to a complex interplay of genetic and external factors all addressing the intracellular network. Increase in sugar or refined carbohydrate consumption results in an increase of insulin and insulin resistance that can lead to the accumulation of fat in the liver. Here we demonstrate how a multidisciplinary approach encompassing cellular reprogramming, transcriptomics, proteomics, metabolomics, modeling, network reconstruction, and data management can be employed to unveil the mechanisms underlying the progression of steatosis. Proteomics revealed reduced AKT/mTOR signaling in fibroblasts derived from steatosis patients and further establishes that the insulin-resistant phenotype is present not only in insulin-metabolizing central organs, e.g., the liver, but is also manifested in skin fibroblasts. Transcriptome data enabled the generation of a regulatory network based on the transcription factor SREBF1, linked to a metabolic network of glycerolipid, and fatty acid biosynthesis including the downstream transcriptional targets of SREBF1 which include LIPIN1 (LPIN) and low density lipoprotein receptor. Glutathione metabolism was among the pathways enriched in steatosis patients in comparison to healthy controls. By using a model of the glutathione pathway we predict a significant increase in the flux through glutathione synthesis as both gamma-glutamylcysteine synthetase and glutathione synthetase have an increased flux. We anticipate that a larger cohort of patients and matched controls will confirm our preliminary findings presented here.
format Online
Article
Text
id pubmed-3432516
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-34325162012-09-11 A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells Jozefczuk, Justyna Kashofer, Karl Ummanni, Ramesh Henjes, Frauke Rehman, Samrina Geenen, Suzanne Wruck, Wasco Regenbrecht, Christian Daskalaki, Andriani Wierling, Christoph Turano, Paola Bertini, Ivano Korf, Ulrike Zatloukal, Kurt Westerhoff, Hans V. Lehrach, Hans Adjaye, James Front Physiol Physiology Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to increase. Differences in susceptibility to steatohepatitis and its progression to cirrhosis have been attributed to a complex interplay of genetic and external factors all addressing the intracellular network. Increase in sugar or refined carbohydrate consumption results in an increase of insulin and insulin resistance that can lead to the accumulation of fat in the liver. Here we demonstrate how a multidisciplinary approach encompassing cellular reprogramming, transcriptomics, proteomics, metabolomics, modeling, network reconstruction, and data management can be employed to unveil the mechanisms underlying the progression of steatosis. Proteomics revealed reduced AKT/mTOR signaling in fibroblasts derived from steatosis patients and further establishes that the insulin-resistant phenotype is present not only in insulin-metabolizing central organs, e.g., the liver, but is also manifested in skin fibroblasts. Transcriptome data enabled the generation of a regulatory network based on the transcription factor SREBF1, linked to a metabolic network of glycerolipid, and fatty acid biosynthesis including the downstream transcriptional targets of SREBF1 which include LIPIN1 (LPIN) and low density lipoprotein receptor. Glutathione metabolism was among the pathways enriched in steatosis patients in comparison to healthy controls. By using a model of the glutathione pathway we predict a significant increase in the flux through glutathione synthesis as both gamma-glutamylcysteine synthetase and glutathione synthetase have an increased flux. We anticipate that a larger cohort of patients and matched controls will confirm our preliminary findings presented here. Frontiers Research Foundation 2012-09-03 /pmc/articles/PMC3432516/ /pubmed/22969728 http://dx.doi.org/10.3389/fphys.2012.00339 Text en Copyright © 2012 Jozefczuk, Kashofer, Ummanni, Henjes, Rehman, Geenen, Wruck, Regenbrecht, Daskalaki, Wierling, Turano, Bertini, Korf, Zatloukal, Westerhoff, Lehrach and Adjaye. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Physiology
Jozefczuk, Justyna
Kashofer, Karl
Ummanni, Ramesh
Henjes, Frauke
Rehman, Samrina
Geenen, Suzanne
Wruck, Wasco
Regenbrecht, Christian
Daskalaki, Andriani
Wierling, Christoph
Turano, Paola
Bertini, Ivano
Korf, Ulrike
Zatloukal, Kurt
Westerhoff, Hans V.
Lehrach, Hans
Adjaye, James
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title_full A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title_fullStr A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title_full_unstemmed A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title_short A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
title_sort systems biology approach to deciphering the etiology of steatosis employing patient-derived dermal fibroblasts and ips cells
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432516/
https://www.ncbi.nlm.nih.gov/pubmed/22969728
http://dx.doi.org/10.3389/fphys.2012.00339
work_keys_str_mv AT jozefczukjustyna asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT kashoferkarl asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT ummanniramesh asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT henjesfrauke asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT rehmansamrina asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT geenensuzanne asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT wruckwasco asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT regenbrechtchristian asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT daskalakiandriani asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT wierlingchristoph asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT turanopaola asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT bertiniivano asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT korfulrike asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT zatloukalkurt asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT westerhoffhansv asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT lehrachhans asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT adjayejames asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT jozefczukjustyna systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT kashoferkarl systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT ummanniramesh systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT henjesfrauke systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT rehmansamrina systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT geenensuzanne systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT wruckwasco systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT regenbrechtchristian systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT daskalakiandriani systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT wierlingchristoph systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT turanopaola systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT bertiniivano systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT korfulrike systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT zatloukalkurt systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT westerhoffhansv systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT lehrachhans systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells
AT adjayejames systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells